Latest news

Voluntis expanding their global pharma collaborations

Novadiscovery announces new clinical simulation collaboration with Takeda

Debiopharm Grants a Worldwide Exclusive License to Merck KGaA, Darmstadt, Germany for the Development and Commercialization of Xevinapant

Nucleai Partners With Sheba Medical Center’s ARC Innovation Center For a New Strategic Data Collaboration

BC Platforms and Genomenon combine forces to improve clinical genomics diagnosis and research

Carevive closes $18m Series C funding round

Novadiscovery closes a SerA extension, Sanofi invests €2.5M to advance the clinical trial simulation platform JINKO

Voluntis announces issuance of a European patent for the intelligent patient support in drug dosing with its Theraxium digital therapeutic…

Transfer of Voluntis shares to the Euronext Growth Paris market as of February 17, 2021